Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia
详细信息 查看全文
- 作者：Blanca Xicoy ; Ulrich Germing ; Marí ; a-José ; Jimenez ; Olga Garcia ; Regina Garcia ; Jeniffer Schemenau ; Carme Pedro ; Elisa Luñ ; o ; Teresa Bernal ; Bernardo Gonzá ; lez ; Corinna Strupp ; Maite Ardanaz ; Andrea Kuendgen ; Marí ; a-Teresa Cedena ; Judith Neukirchen ; Marisa Calabuig ; Salut Brunet ; Angeles Medina ; Marí ; a-Luz Amigo ; Fernando Ramos ; Marta Callejas ; Marí ; a Dí ; ez-Campelo ; Alicia Bailé ; n ; Rosa Collado ; Ana Vicente ; Montserrat Arnan ; David Valcarcel ; Marí ; a Jesú ; s Arilla ; Lurdes Zamora ; Luis Benlloch and Guillermo Sanz
- 刊名：European Journal of Haematology
- 出版年：2016
- 出版时间：July 2016
- 年：2016
- 卷：97
- 期：1
- 页码：33-38
- 全文大小：234K
- ISSN：1600-0609
文摘
The efficacy of erythropoietic-stimulating agents (ESA) in chronic myelomonocytic leukemia (CMML) is unknown. Our objective was to analyze erythroid response (ER) and overall survival (OS) in a series of 94 patients with CMML treated with ESA.